Kim Rivers Sells 380,000 Shares of Trulieve Cannabis (NYSE:TRLV) Stock

Trulieve Cannabis Corp. (NYSE:TRLV) CEO Kim Rivers sold 380,000 shares of the business’s stock in a transaction dated Tuesday, June 23rd. The shares were sold at an average price of $8.47, for a total value of $3,218,600.00. Following the completion of the sale, the chief executive officer owned 2,313,724 shares in the company, valued at approximately $19,597,242.28. This trade represents a 14.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Trulieve Cannabis Stock Performance

TRLV stock opened at $8.93 on Friday. Trulieve Cannabis Corp. has a fifty-two week low of $3.50 and a fifty-two week high of $13.28.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on TRLV shares. Zacks Research raised Trulieve Cannabis to a “hold” rating in a research report on Thursday, June 18th. Weiss Ratings assumed coverage on shares of Trulieve Cannabis in a report on Tuesday, June 16th. They issued a “sell (d-)” rating on the stock. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Reduce”.

About Trulieve Cannabis

Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.

Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.